Aquilo is operated by an experienced team with a longstanding experience in respiratory research. The team has extensive knowledge on the pathophysiology of lung diseases, and experience with relevant in vitro and ex vivo techniques and with animal models for lung diseases. Furthermore, Aquilo has functioned as a core lab in multi-center clinical trials evaluating novel therapies for asthma and COPD.
The strong scientific background is reflected by over 100 scientific publications on the different models described in the portfolio.
Loes Kistemaker (PharmD, PhD) is CEO at Aquilo. After obtaining a Masters Degree in Pharmacy from the University of Groningen, Loes was trained as a pharmacologist during her PhD and post-doctoral studies in the Department of Molecular Pharmacology at the University of Groningen.
Reinoud Gosens (PhD) is Professor in Translational Pharmacology at the Faculty of Science and Engineering of the University of Groningen. He obtained his PhD in pharmacology in 2004 at the University of Groningen and performed his postdoctoral studies at the University of Manitoba, Canada until 2007.
Professor Reinoud Gosens is scientific advisor of Aquilo.